Advances in Cancer Immunotherapy™ is a CME- and CE-certified program for clinical oncologists, registered nurses, pharmacists and others involved in treating cancer patients with immunotherapy to learn basic immunology principles and the mechanisms and clinical applications of immunotherapy. ...
This webinar on November 21st examined how biomarkers are used to define “PD-L1” positive patients around the globe and in resource limited settings. It provided a forum for physicians to discuss their experience assessing different criteria, as well as the solutions that were implemented to...
This webinar on October 16th examined the importance of monitoring response to cancer immunotherapy, with a specific focus on image evaluation and predictive AI. The program featured discussions from leading scientists and radiologists in the field of IO on how feasible these tools are in a...
Thousands of IO clinical trials are currently available to cancer patients, all of which are aiming to identify the next generation of potential life-saving treatments. However, it can be difficult to design trials that will be able to efficiently enroll patients, especially in the field of...
This webinar on September 26th examined how rare and challenging cases, such as extremes of age, immunocompromised, autoimmune conditions, co-morbidities, pregnancy, and transplant cases impact immunotherapy treatment around the globe and in resource limited settings. It featured physicians from...
Increased understanding of immunotherapy mechanisms of action may enhance researchers’ ability to circumvent resistance and identify alternative therapeutic uses. Imaging-based AI that can closely analyze drug-specific structures and interactions are being developed to help expedite discoveries...
This webinar on August 15th examined how immune checkpoint inhibitors are being utilized around the globe and in resource limited settings. It provided a forum for physicians from Brazil, Lebanon, and Malawi to discuss their experience in evaluating checkpoint inhibitors as a treatment option as...
Social determinants of health are becoming increasingly understood as having significant impact in immunotherapy patient care. Many of these determinants are captured in the electronic health record (EHR), but very few methods can effectively analyze these data to better determine correlations...
In Cancer Immunotherapy Patient CONNECT, explore resources, connect to cancer patients in the general discussion forum, and learn of educational opportunities for cancer patients and those who advocate for them. SITC Patient Resources Welcome to SITC Cancer Immunotherapy connectED! SITC...
This webinar on July 10th examined how cell therapies are being utilized around the globe and in resource limited settings. It featured physicians from India, Mexico, and Egypt to discuss their experience in evaluating cell therapies as a treatment option as well as how they overcame challenges...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us